DeuteRx's Seed Round

DeuteRx raised a round of funding on September 30, 2015.

DeuteRx is focused on 'deuterium-enabled chiral switching' (DECS), an approach to improve racemic (a mixture of two mirror-image compounds or enantiomers) small molecule marketed drugs and drug candid…

Articles about DeuteRx's Seed Round: